What is the initial management for a patient presenting with a ureteric stone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Initial Management of Ureteric Stones

For patients presenting with ureteric stones ≤10 mm, initiate conservative management with alpha-blockers (medical expulsive therapy) combined with NSAIDs for pain control, while monitoring with periodic imaging over 4-6 weeks. 1

Immediate Assessment Requirements

Before initiating conservative management, confirm the patient meets these criteria:

  • Well-controlled pain with oral analgesics 1
  • No clinical evidence of sepsis 1
  • Adequate renal functional reserve 1
  • Obtain urine microscopy and culture to exclude or treat UTI before any treatment 1
  • Confirm stone size and location with appropriate imaging (preferably low-dose non-contrast CT) 1

First-Line Pain Management

NSAIDs are the primary analgesics for renal colic and should be used at the lowest effective dose to minimize cardiovascular and gastrointestinal risks. 1, 2 Options include diclofenac, ibuprofen, or metamizole. 2

  • NSAIDs are superior to opioids, reducing the need for additional analgesia and providing more effective pain control than antispasmodics 2
  • Reserve opioids as second-line therapy only when NSAIDs are contraindicated or insufficient 1, 2
  • Avoid NSAIDs in patients with significantly reduced GFR or active gastrointestinal disease 1, 2

Medical Expulsive Therapy (MET)

Alpha-blockers are the cornerstone of medical expulsive therapy, showing greatest benefit for stones >5 mm in the distal ureter. 1, 2 Options include tamsulosin, terazosin, or doxazosin. 2

  • Alpha-blockers increase stone passage rates by 29% compared to control patients 2
  • Counsel patients that alpha-blockers are used off-label for this indication and discuss potential side effects 1, 2
  • Most stones that pass spontaneously do so within approximately 17 days (range 6-29 days) 3

Mandatory Monitoring Protocol

Follow patients with periodic imaging (low-dose CT or ultrasound) to monitor stone position and assess for hydronephrosis. 1, 3

  • Maximum duration of conservative management is 4-6 weeks from initial presentation 1, 3
  • Do not delay intervention beyond 6 weeks, as this risks irreversible kidney damage 1
  • Schedule follow-up with urology within 2-4 weeks if the stone has not passed 3

Urgent Intervention Requirements

Immediate decompression via percutaneous nephrostomy or ureteral stenting is mandatory for: 1, 2

  • Sepsis or uncontrolled infection
  • Anuria (complete cessation of urine output)
  • Uncontrolled pain despite adequate analgesia

Do not use alpha-blockers in patients with sepsis or significant obstruction requiring urgent decompression. 1

Elective Intervention Indications

Proceed to definitive treatment if: 1

  • Failed conservative management after 4-6 weeks
  • Uncontrolled pain despite optimal medical therapy
  • Development of fever or signs of infection
  • Progressive hydronephrosis on follow-up imaging

For stones <10mm requiring intervention, ureteroscopy (URS) is the first surgical option, though shockwave lithotripsy (SWL) is an equivalent alternative. 1, 3 URS yields significantly greater stone-free rates but has slightly higher complication rates. 3

Special Considerations for Specific Stone Types

For uric acid stones, oral chemolysis with alkalinization is strongly recommended, with a success rate of 80.5%. 1 Potassium citrate should be used to raise urinary pH to 6.0. 4

References

Guideline

Medical Management of Ureteral Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pain Control Medications for Ureteral Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Discharge Instructions for Kidney Stone in Ureter

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

medical management of kidney stones: aua guideline.

The Journal of urology, 2014

Related Questions

What is the initial management for a patient with a 6 mm kidney stone at the inner left ureterovesical junction (UVJ) with mild hydronephrosis and hydroureter?
What is the process of retrieving kidney stones with a basket?
What is the appropriate management for a patient with an obstructing ureteral stone, urinary tract infection, proteinuria, hypertension, and bradycardia?
What is the gold‑standard treatment for a 1.6 cm left upper ureteric obstructive stone with 500 HU density, moderate hydronephrosis and perinephric fat stranding, and two 3 mm non‑obstructive middle‑calyceal stones of 300 HU – should it be extracorporeal shock wave lithotripsy (ESWL) or complex ureteroscopy?
What is the recommended management for a patient with a ureteric calculus causing hydronephrosis?
What are the considerations for using Angiotensin-Converting Enzyme (ACE) inhibitors or Angiotensin Receptor Blockers (ARB) in patients undergoing hemodialysis with hypertension or heart failure?
What is the recommended treatment for a 3-year-old child diagnosed with measles?
What does a stat dose infusion of 100ml paracetamol (acetaminophen) mean in a clinical setting?
What are the contra-indications to iron tablets in patients with Iron Deficiency Anemia (IDA)?
What is the appropriate management for a female patient presenting with T wave inversion in leads V1, V2, and V3 on an electrocardiogram (ECG)?
What is the recommended cough syrup for a patient with acute cough, considering potential dependence and side effects, and taking into account a possible history of asthma or Chronic Obstructive Pulmonary Disease (COPD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.